San Draw, founded in 2014 by Stanford alumni Gary Chang and Michael Lu, is a medical organization based in San Jose, California. The company specializes in silicone 3D printing technology, offering a range of printers and materials designed for biocompatible applications. Their product lineup includes the S053, S180, and S300 models, each tailored for different scales and complexities of medical printing needs. San Draw aims to revolutionize the medical field by providing advanced, customizable solutions for prosthetics, implants, and other critical healthcare components.
Notable figures associated with San Draw include its founders, Gary Chang and Michael Lu, who bring their expertise from Stanford University to drive innovation. The company has secured patents for its FAM technology, underscoring its commitment to cutting-edge advancements. San Draw's impact is evident in its contributions to the medical industry, particularly in enhancing the precision and biocompatibility of 3D-printed medical devices. Their work not only improves patient outcomes but also sets new standards in medical manufacturing.
Quick Facts
When was San Draw's last funding round?
San Draw's most recent funding round was for $1.2M (USD) in January 2019.
How much disclosed funding has San Draw raised?
As of Jan 1, 2019, San Draw has disclosed funding of $1.2M (USD).